Brief: JCR Pharmaceuticals Co Ltd And Takeda Pharmaceuticals Announce Discontinuation Of Gene Therapy Collaboration
20/12/2023 07:06
Dec 20 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T :
* JCR PHARMACEUTICALS CO LTD AND TAKEDA PHARMACEUTICALS ANNOUNCE
DISCONTINUATION
OF GENE THERAPY COLLABORATION
Source text for Eikon: ID:nTSxt7b8c7
Further company coverage: 4502.T
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results